Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review

Front Endocrinol (Lausanne). 2023 Apr 21:14:1129622. doi: 10.3389/fendo.2023.1129622. eCollection 2023.

Abstract

Pheochromocytomas (PCC)/paragangliomas (PGL) are catecholamine (CA) -secreting neuroendocrine tumors, which are known as PPGL due to their histological and pathophysiological similarities. In addition to the typical triad of paroxysmal headache, palpitation, and sweating, PPGL may also be accompanied by symptoms and signs involving multiple organs and systems such as the cardiovascular system, digestive system, endocrine system, and nervous system. Currently, surgical resection is the first choice for PPGL. Safe and effective surgical management of complicated PPGL is the goal of clinical work. In this paper, we discuss this hot issue based on complicated PPGL cases, aiming to share our experience of the surgical management strategy of PPGL.

Keywords: catecholamine; multidisciplinary treatment; paragangliomas; pheochromocytomas; surgery.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Gland Neoplasms* / diagnosis
  • Catecholamines
  • Humans
  • Neuroendocrine Tumors*
  • Paraganglioma* / pathology
  • Pheochromocytoma* / pathology

Substances

  • Catecholamines

Grants and funding

This study was funded by the National High Level Hospital Clinical Research Funding (2022-PUMCH-B-010).